Case number 1:22-cv-00294
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 26, 2023 | 153 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendant Alvogen, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (2) Plaintiffs' First Amended Disclosures to Defendant Alvogen, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (3) Plaintiffs' First Amended Disclosures to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (4) Plaintiffs' First Amended Disclosures to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (5) Plaintiffs' First Amended Disclosures to Defendants Rio Biopharmaceuticals Inc. and EMS S/A Under Paragraph 3 of the District of Delaware Default Standard, (6) Plaintiffs' First Amended Disclosures to Defendants Rio Biopharmaceuticals Inc. and EMS S/A Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (7) Plaintiffs' Second Amended Disclosures to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (8) Plaintiffs' Second Amended Disclosures to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (9) Plaintiffs' Second Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard, and (10) Plaintiffs' Second Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/26/2023) (11) |
| Jun 23, 2023 | 151 | STIPULATION TO EXTEND TIME Joint Stipulation Extending Deadline for Substantial Completion of Document Production to June 30, 2023 - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 06/23/2023) (6) |
| Jun 23, 2023 | 152 | SO ORDERED, re (104 in 1:22-cv-01040-CFC, 138 in 1:22-md-03038-CFC, 151 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME Joint Stipulation Extending Deadline for Substantial Completion of Document Production to June 30, 2023, filed by Rio Biopharmaceuticals, Inc., EMS S/A. Setting Scheduling Order Deadlines: Discovery due by 6/30/2023. Signed by Judge Colm F. Connolly on 6/23/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 06/23/2023) (6) |
| Jun 8, 2023 | 150 | REDACTED VERSION of (148 in 1:22-cv-00294-CFC, 135 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/08/2023) (3) |
| Jun 2, 2023 | 149 | [SEALED] SO ORDERED, re (148 in 1:22-cv-00294-CFC, 135 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '154 Patent, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 6/2/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 06/02/2023) (0) |
| Jun 1, 2023 | 148 | [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '154 Patent - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/01/2023) (0) |
| May 30, 2023 | 147 | SO ORDERED, re (133 in 1:22-md-03038-CFC, 146 in 1:22-cv-00294-CFC, 102 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to June 23, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Setting Deadlines: Discovery due by 6/23/2023. Signed by Judge Colm F. Connolly on 5/30/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 05/30/2023) (5) |
| May 26, 2023 | 146 | STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to June 23, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/26/2023) (5) |
| May 23, 2023 | 145 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/23/2023) (30) |
| May 19, 2023 | 144 | STIPULATION and [Proposed] Order to Extend the Deadline to Submit Amended Joint Claim Construction Chart to and including May 23, 2023 by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/19/2023) (5) |
| May 16, 2023 | 143 | REDACTED VERSION of (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal, as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '154, '239, '611, '155, '063, and '363 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/16/2023) (4) |
| May 15, 2023 | 142 | SO ORDERED, re (98 in 1:22-cv-01040-CFC, 141 in 1:22-cv-00294-CFC, 128 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME to submit an amended joint claim construction chart to May 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/15/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 05/15/2023) (4) |
| May 12, 2023 | 141 | STIPULATION TO EXTEND TIME to submit an amended joint claim construction chart to May 19, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/12/2023) (4) |
| May 11, 2023 | 140 | [SEALED] SO ORDERED, re (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/11/2023.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 05/11/2023) (0) |
| May 10, 2023 | 139 | [SEALED] STIPULATION of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/10/2023) (0) |
| May 8, 2023 | 138 | REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Main Document) (13) |
| May 8, 2023 | 138 | REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Exs. A-L) (30) |
| May 8, 2023 | 138 | REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Exs. 1-14) (30) |
| May 5, 2023 | 137 | [SEALED] Joint APPENDIX re (119 in 1:22-md-03038-CFC) Joint Claim Construction Brief, (91 in 1:22-cv-01040-CFC) Joint Claim Construction Brief, (136 in 1:22-cv-00294-CFC) Joint Claim Construction Brief - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/05/2023) (0) |
| May 1, 2023 | 136 | JOINT CLAIM CONSTRUCTION BRIEF - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 05/01/2023) (30) |
| Apr 27, 2023 | 135 | NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/27/2023) (2) |
| Apr 25, 2023 | 134 | NOTICE OF SERVICE of Alvogen, Inc.'s First Amended and Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(DiBenedetto, Emily) (Entered: 04/25/2023) (2) |
| Apr 6, 2023 | 133 | NOTICE OF SERVICE of (1) Novo Nordisk's Reply Claim Construction Brief and (2) Declaration of Laura T. Moran in Support of Novo Nordisk A/S and Novo Nordisk Inc.'s Reply Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 04/06/2023) (12) |
| Mar 17, 2023 | 132 | NOTICE OF SERVICE of copies of (i) Defendants' Answering Claim Construction Brief; and, (ii) Declaration of Karl R. Leinsing, MSME, PE filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 03/17/2023) (2) |
| Mar 7, 2023 | 130 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Alvogen filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/07/2023) (3) |
| Mar 7, 2023 | 131 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to DRL Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/07/2023) (3) |
| Mar 6, 2023 | 129 | NOTICE OF SERVICE of Plaintiffs' First Amended Infringement Contentions Regarding the '343 Patent (Individual Sets Served on Each Defendant Group) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/06/2023) (12) |
| Feb 24, 2023 | 128 | NOTICE OF SERVICE of Novo Nordisk's Opening Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/24/2023) (12) |
| Feb 9, 2023 | 126 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/09/2023) (4) |
| Feb 9, 2023 | 127 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to RIO Defendants, Sun Defendants, Alvogen and DRL Defendants (separate disclosure sent to each defendant group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/09/2023) (9) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Main Document) (30) |
| Feb 3, 2023 | 124 | MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/03/2023) (7) |
| Feb 3, 2023 | 125 | MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 02/03/2023) (5) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex A - '383 Patent) (15) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex B - '154 Patent) (24) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex C - '953 Patent) (16) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex D - '462 Patent) (26) |
| Feb 2, 2023 | 122 | SO ORDERED, re (73 in 1:22-cv-01040-CFC, 96 in 1:22-md-03038-CFC, 121 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Joint Claim Construction Chart due by 2/3/2023. Claim Construction Opening Brief due by 2/24/2023. Claim Construction Answering Brief due by 3/17/2023. Claim Construction Reply Brief due by 4/6/2023. Claim Construction Surreply Brief due by 4/26/2023. Signed by Judge Colm F. Connolly on 2/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 02/02/2023) (5) |
| Feb 1, 2023 | 121 | STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/01/2023) (5) |
| Jan 31, 2023 | 119 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk Commercial Holdings, Inc., Other Affiliate Novo Nordisk A/S, Other Affiliate Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Holdings A/S, Other Affiliate Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/31/2023) (7) |
| Jan 31, 2023 | 120 | REDACTED VERSION of (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 01/31/2023) (4) |
| Jan 27, 2023 | 117 | [SEALED] SO ORDERED, re (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Colm F. Connolly on 1/27/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 118 | NOTICE OF SERVICE of Plaintiffs' Notice to Sun of Subpoena for Production of Documents (confidential as to Sun Pharmaceutical Industries Ltd. And Sun Pharmaceutical Industries, Inc.) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/27/2023) (8) |
| Jan 26, 2023 | 116 | [SEALED] STIPULATION of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 01/26/2023) (0) |
| Jan 25, 2023 | 115 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/25/2023) (12) |
| Jan 24, 2023 | 114 | NOTICE OF SERVICE of Defendants Proposed Constructions and Intrinsic Evidence (with Exhibit A) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 01/24/2023) (2) |
| Jan 23, 2023 | 109 | NOTICE OF SERVICE of (1) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Collective Interrogatories (No. 14); and (2) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Requests for Production (Nos. 93-98) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 110 | NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 74-91) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 111 | NOTICE OF SERVICE of (i) DRL's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and, (ii) DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 95-100) filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 112 | NOTICE OF SERVICE of (1) Sun's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) and (2) Sun's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 77-82) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 113 | NOTICE OF SERVICE of 1. Alvogen's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 89-94) 2. Alvogen's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) filed by Alvogen, Inc..(Keller, Karen) (Entered: 01/23/2023) (2) |
| Jan 19, 2023 | 108 | NOTICE OF SERVICE of Plaintiffs' Identification of Inventors Employed by Plaintiffs and/or Represented by Counsel for Plaintiffs - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/19/2023) (11) |
| Jan 13, 2023 | 107 | NOTICE OF SERVICE of Defendants' List of Proposed Terms for Construction filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 01/13/2023) (2) |
| Jan 12, 2023 | 106 | NOTICE OF SERVICE of Plaintiffs' Preliminary Identification of Claim Terms Requiring Construction Pursuant to Paragraph 19 of the Scheduling Order (C.A. No. 22-294-CFC at D.I. 22; C.A. No. 22-1040-CFC at D.I. 53) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/12/2023) (11) |
| Jan 4, 2023 | 104 | STIPULATION and [Proposed] Order to Extend Certain Claim Construction Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/04/2023) (5) |
| Jan 4, 2023 | 105 | SO ORDERED, re (77 in 1:22-md-03038-CFC, 64 in 1:22-cv-01040-CFC, 104 in 1:22-cv-00294-CFC) Stipulation to Extend Certain Claim Construction Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/4/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 01/04/2023) (5) |
| Dec 22, 2022 | 102 | NOTICE OF SERVICE of Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/22/2022) (11) |
| Dec 22, 2022 | 103 | NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Individual Requests Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/22/2022) (9) |
| Dec 21, 2022 | 101 | NOTICE OF SERVICE of Novo Nordisk's Initial Responses to Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/21/2022) (11) |
| Dec 16, 2022 | 96 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's Second Set of Collective Interrogatories (No. 13) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 97 | NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Collective Interrogatories (No. 13) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 98 | NOTICE OF SERVICE of Alvogen's Responses and Objections to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Alvogen, Inc..(Keller, Karen) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 99 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs Second Set of Collective Interrogatories to Defendants (No. 13) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 100 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions (Individual Sets Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) (Entered: 12/16/2022) (11) |
| Dec 15, 2022 | 95 | NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 12/15/2022) (2) |
| Dec 8, 2022 | 94 | NOTICE of Appearance by Alexis Stombaugh on behalf of Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Stombaugh, Alexis) (Entered: 12/08/2022) (3) |
| Dec 1, 2022 | 93 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/01/2022) (3) |
| Nov 22, 2022 | 92 | NOTICE OF SERVICE of (1) Plaintiffs' Response to Defendants' First Set of Interrogatories (Nos. 1-4); and (2) Plaintiffs' Response to Defendants' First Set of Requests for Production (Nos. 1-23) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/22/2022) (11) |
| Nov 21, 2022 | 91 | REDACTED VERSION of (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/21/2022) (4) |
| Nov 18, 2022 | 90 | NOTICE OF SERVICE of Defendants' Identification of Prior Art to Supplement Defendants' Initial Invalidity Contentions filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 11/18/2022) (2) |
| Nov 16, 2022 | 89 | NOTICE OF SERVICE of Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/16/2022) (11) |
| Nov 15, 2022 | 88 | [SEALED] SO ORDERED, re (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/15/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) Modified on 11/16/2022 (kmd). (Entered: 11/15/2022) (0) |
| Nov 14, 2022 | 87 | [SEALED] STIPULATION of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint) by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/14/2022) (0) |
| Nov 8, 2022 | 85 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/08/2022) (4) |
| Nov 8, 2022 | 86 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard to the Sun Defendants and (2) Plaintiffs' First Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure to the Sun Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/08/2022) (5) |
| Nov 3, 2022 | 84 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 11/03/2022) (2) |
| Oct 27, 2022 | 80 | NOTICE OF SERVICE of DEFENDANTS RIO BIOPHARMACEUTICALS INC. AND EMS S/AS OBJECTIONS AND RESPONSES TO PLAINTIFFS SECOND SET OF REQUESTS FOR PRODUCTION OF DOCUMENTS (NOS. 11-92) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 10/27/2022) (2) |
| Oct 27, 2022 | 81 | NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-76) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/27/2022) (2) |
| Oct 27, 2022 | 82 | NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 10/27/2022) (2) |
| Oct 27, 2022 | 83 | NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11 - 88) filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 10/27/2022) (2) |
| Oct 20, 2022 | 72 | [SEALED] SO ORDERED, re (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/20/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 10/20/2022) (0) |
| Oct 20, 2022 | 73 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Noninfringement Contentions Regarding Claims 12-14 of the '154 Patent filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 74 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Noninfringement Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 75 | NOTICE OF SERVICE of copy of DRL's Noninfringement Contentions [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 76 | NOTICE OF SERVICE of Sun's Initial Non-Infringement Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 77 | NOTICE OF SERVICE of Alvogen, Inc.'s Preliminary Non-Infringement Contentions filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 78 | MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit - filed by Alvogen, Inc.. (Hoeschen, Nathan) (Entered: 10/20/2022) (4) |
| Oct 20, 2022 | 79 | NOTICE OF SERVICE of Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Metzler, Sara) (Entered: 10/20/2022) (3) |
| Oct 19, 2022 | 70 | [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/19/2022) (0) |
| Oct 19, 2022 | 71 | REDACTED VERSION of (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/19/2022) (3) |
| Oct 14, 2022 | 69 | NOTICE of Withdrawal of Joshua S. Reisberg by Alvogen, Inc. (Keller, Karen) (Entered: 10/14/2022) (2) |
| Oct 13, 2022 | 68 | ANSWER to Amended Complaint, re: 63 Amended Complaint by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/13/2022) (27) |
| Oct 7, 2022 | 64 | NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 65 | NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 66 | NOTICE OF SERVICE of Defendants Responses to Plaintiffs First Set of Collective Interrogatories (Nos. 1-12) filed by Alvogen, Inc..(Keller, Karen) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 67 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Collective Interrogatories (Nos. 1-12) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/07/2022) (2) |
| Sep 29, 2022 | 63 | Amended Complaint* (1) |
| Aug 5, 2022 | 48 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [40] Amended Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) |
| Aug 4, 2022 | 46 | Proposed Order (30) Docket Text: PROPOSED ORDER --- Protective Order by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Aug 4, 2022 | 47 | Stipulation (17) Docket Text: STIPULATION -- Stipulated Order Regarding the Discovery of Electronically Stored Information by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Jul 29, 2022 | 45 | SO ORDERED (4) Docket Text: SO ORDERED, re [44] STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information and a proposed Protective Order to August 4, 2022, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 7/29/2022. (kmd) |
| Jul 28, 2022 | 44 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information and a proposed Protective Order to August 4, 2022 - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) |
| Jul 22, 2022 | 42 | SO ORDERED (6) Docket Text: SO ORDERED, re [41] STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to July 28, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 7/22/2022. (kmd) |
| Jul 22, 2022 | 43 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2 ;8,920,383 B2 ;9,457,154 B2 ;9,775,953 B2 ;9,132,239 B2 ;10,335,462 B2 . (Egan, Brian) |
| Jul 21, 2022 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (nmf) |
| Jul 21, 2022 | 38 | Main Document (6) Docket Text: MOTION for Leave to File Amended Complaint Against Sun (Unopposed) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibits A-F to First Amended Complaint, # (3) Exhibit 2)(Egan, Brian) |
| Jul 21, 2022 | 38 | Exhibit 1 (17) |
| Jul 21, 2022 | 38 | Exhibits A-F to First Amended Complaint (161) |
| Jul 21, 2022 | 38 | Exhibit 2 (19) |
| Jul 21, 2022 | 39 | SO ORDERED (2) Docket Text: SO ORDERED, re [38] MOTION for Leave to File Amended Complaint Against Sun (Unopposed), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 7/21/2022. (kmd) |
| Jul 21, 2022 | 40 | Main Document (17) Docket Text: AMENDED COMPLAINT against Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd.- filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibits A-F)(kmd) |
| Jul 21, 2022 | 40 | Exhibit A-F (161) |
| Jul 21, 2022 | 41 | Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to July 28, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Jul 21, 2022 | 40 | Amended Complaint* (1) |
| Jul 14, 2022 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Initial Disclosures Pursuant 2 to Rule 26(a)(1); and, (ii) Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) |
| Jul 14, 2022 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery, and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) |
| Jul 14, 2022 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries Inc.'s Initial and Paragraph 3 Disclosures filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Farnan, Kelly) |
| Jul 14, 2022 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (Alvogen) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 34 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (DRL Defendants) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 36 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (Sun Defendants) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 37 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (Zydus Defendants) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 13, 2022 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Rio Biopharmaceuticals Inc. and EMS S/A 's 26(a)(1) Initial Disclosures and; (2) Rio Biopharmaceuticals Inc. and EMS S/A 's Paragraph 3 Disclosures filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) |
| Jul 13, 2022 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Alvogen, Inc.'s Rule 26(a)(1) Initial Disclosures (2) Alvogen, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(Hoeschen, Nathan) |
| Jul 12, 2022 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendant Alvogen, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 24 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Rio Biopharmaceuticals Inc. and EMS S/A filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 26 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Sun Pharmaceuticals Ltd. and Sun Pharmaceutical Industries, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 27 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jun 30, 2022 | 22 | Scheduling Order (30) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 22-294-CFC ONLY. Joinder of Parties due by 8/1/2023. Amended Pleadings due by 8/1/2023. Fact Discovery completed by 10/20/2023. Expert Discovery due by 5/24/2024. Joint Claim Construction Brief due by 5/1/2023. A Markman Hearing is set for 6/29/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 8/29/2024. A Final Pretrial Conference is set for 9/19/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/30/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/29/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 29, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 6/29/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [21] MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Philip Y. Kouyoumdjian and Attorney Jaimin H. Shah, filed by Rio Biopharmaceuticals, Inc., EMS S/A. Ordered by Judge Colm F. Connolly on 6/28/2022. (kmd) |
| Jun 28, 2022 | 21 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Philip Y. Kouyoumdjian and Attorney Jaimin H. Shah - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) |
| Jun 27, 2022 | 20 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding the Court's June 6, 2022 Order - re (19 in 1:22-cv-00294-CFC, 21 in 1:22-cv-00298-CFC, 19 in 1:22-cv-00296-CFC, 20 in 1:22-cv-00299-CFC, 25 in 1:22-cv-00297-CFC) Order Setting Scheduling Conference,. (Attachments: # (1) [Proposed] Scheduling Order)(Egan, Brian) |
| Jun 27, 2022 | 20 | [Proposed] Scheduling Order (38) |
| Jun 6, 2022 | 19 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 6/29/2022 at 04:00 PM Telephonically before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 6/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 3, 2022 | 18 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding coordinated discovery and Markman proceedings - re (13 in 1:22-cv-00296-CFC, 13 in 1:22-cv-00296-CFC, 15 in 1:22-cv-00294-CFC, 15 in 1:22-cv-00294-CFC, 19 in 1:22-cv-00297-CFC, 19 in 1:22-cv-00297-CFC, 15 in 1:22-cv-00299-CFC, 15 in 1:22-cv-00299-CFC, 17 in 1:22-cv-00298-CFC, 17 in 1:22-cv-00298-CFC) Order,,, Set Deadlines,,. (Egan, Brian) |
| May 31, 2022 | 17 | Answer to Counterclaim (16) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim - by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| May 24, 2022 | 16 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Kara Czekai as co-counsel. Reason for request: No longer with firm. (Egan, Brian) |
| May 11, 2022 | 15 | Order (3) Docket Text: ORDER: IT IS ORDERED that, on or before June 13, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 6/13/2022.) Signed by Judge Colm F. Connolly on 5/11/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| May 9, 2022 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) |
| May 9, 2022 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Rio Biopharmaceuticals, Inc. for EMS S/A filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) |
| May 9, 2022 | 13 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Rio Biopharmaceuticals Inc.'s production of core technical documents pursuant to Chief Judge Connolly's Standing Order on Hatch Waxman cases filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) |
| May 9, 2022 | 14 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding JPML filing. (Attachments: # (1) Attachment)(Egan, Brian) |
| May 9, 2022 | 14 | Attachment (1209) |
| May 6, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:22-cv-00298-CFC, 10 in 1:22-cv-00294-CFC, 13 in 1:22-cv-00297-CFC, 10 in 1:22-cv-00296-CFC, 9 in 1:22-cv-00299-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 5/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC. (kmd) |
| May 6, 2022 | 10 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME for Rio Biopharmaceuticals Inc. and EMS S/A to answer, move or otherwise respond to the Complaint to May 9, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Rio Biopharmaceuticals, Inc. answer due 5/9/2022. Ordered by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 11, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For EMS S/A waiver sent on 3/8/2022, answer due 5/9/2022. (Egan, Brian) |
| Mar 11, 2022 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Rio Biopharmaceuticals Inc. and EMS S/A to answer, move or otherwise respond to the Complaint to May 9, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Mar 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-00294-CFC through 1:22-cv-00299-CFC (rjb) |
| Mar 7, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Rio Biopharmaceuticals, Inc. served on 3/7/2022, answer due 3/28/2022. (Egan, Brian) |
| Mar 4, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT filed against EMS S/A and Rio Biopharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3817543.) - filed by Novo Nordisk Inc. and Novo Nordisk A/S. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(mal) |
| Mar 4, 2022 | 1 | Exhibit A-E (146) |
| Mar 4, 2022 | 1 | Civil Cover Sheet (1) |
| Mar 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Mar 4, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/24/2022. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 06/05/2025. (mal) |
| Mar 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2 ;9,132,239 B2 ;9,457,154 B2 ;9,687,611 B2 ;10,335,462 B2. (mal) |
| Mar 4, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo A/S for Novo Nordisk A/S; Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc.. (mal) |
| Mar 4, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to EMS S/A on 3/4/2022; Rio Biopharmaceuticals, Inc. on 3/4/2022. (Attachments: # (1) Summons Issued EMS S/A)(mal) |
| Mar 4, 2022 | 6 | Summons Issued EMS S/A (2) |
| Mar 4, 2022 | 1 | Complaint* (1) |
